Fine tuning T lymphocytes: A role for the lipid phosphatase SHIP-1

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1804, Issue 3, 2010, Pages 592-597

  Parry, Richard V ^a   Harris, Stephanie J ^a   Ward, Stephen G ^a  

^a University of Bath   (United Kingdom)

Author keywords

Chemotaxis; Lipid phosphatase; miRNA; PI3K; T Lymphocyte; TReg

Indexed keywords

CD28 ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MICRORNA; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; SHIP 1 PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; ENZYME ACTIVE SITE; HUMAN; IMMUNE FUNCTION TEST; IMMUNOGLOBULIN BLOOD LEVEL; INSULIN RESISTANCE; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TH2 CELL;

ANIMALS; AUTOIMMUNE DISEASES; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; INFLAMMATION; PHOSPHORIC MONOESTER HYDROLASES; SRC HOMOLOGY DOMAINS; T-LYMPHOCYTES;

EID: 75349096225     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2009.09.019     Document Type: Review

References (83)

1. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Katso R., Driscoll P.C., Woscholski R., Parker P.J., and Waterfield M.D. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70 (2001) 535-602
2. Parry R.V., Whittaker G.C., Sims M., Edmead C.E., Welham M.J., and Ward S.G. Ligation of CD28 stimulates the formation of a multimeric signaling complex involving Grb-2-associated binder 2 (Gab2), SRC homology phosphatase-2, and phosphatidylinositol 3-kinase: evidence that negative regulation of CD28 signaling requires the Gab2 pleckstrin homology domain. J. Immunol. 176 (2006) 594-602
3. Marone R., Cmiljanovic V., Giese B., and Wymann M.P. Targeting phosphoinositide 3-kinase: moving towards therapy. Biochim. Biophys. Acta 1784 (2008) 159-185
4. Okkenhaug K., and Vanhaesebroeck B. PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 3 (2003) 317-330
5. Vanhaesebroeck B., Ali K., Bilancio A., Geering B., and Foukas L.C. Signalling by PI3K isoforms: insights from gene-targeted mice. Trends Biochem. Sci. 30 (2005) 194-204
6. Damen J.E., Liu L., Rosten P., Humphries R.K., Jefferson A.B., Majerus P.W., and Krystal G. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 1689-1693
7. Di Cristofano A., Pesce B., Cordon-Cardo C., and Pandolfi P.P. PTEN is essential for embryonic development and tumour suppression. Nat. Genet. 19 (1998) 348-355
8. Cully M., You H., Levine A.J., and Mak T.W. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer 6 (2006) 184-192
9. Ward S.G., and Cantrell D.A. Phosphoinositide 3-kinases in T lymphocyte activation. Curr. Opin. Immunol. 13 (2001) 332-338
10. Parry R.V., Riley J.L., and Ward S.G. Signalling to suit function: tailoring phosphoinositide 3-kinase during T-cell activation. Trends Immunol. 28 (2007) 161-168
11. Ward S.G., and Marelli-Berg F.M. Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation. Biochem. J. 418 (2009) 13-27
12. Guillermet-Guibert J., Bjorklof K., Salpekar A., Gonella C., Ramadani F., Bilancio A., Meek S., Smith A.J., Okkenhaug K., and Vanhaesebroeck B. The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 8292-8297
13. Deane J.A., and Fruman D.A. Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu. Rev. Immunol. 22 (2004) 563-598
14. Okkenhaug K., Bilancio A., Farjot G., Priddle H., Sancho S., Peskett E., Pearce W., Meek S.E., Salpekar A., Waterfield M.D., Smith A.J.H., and Vanhaesebroeck B. Impaired B and T cell antigen receptor signaling in p110delta PI 3-Kinase mutant mice. Science 297 (2002) 1031-1034
15. Patton D.T., Garden O.A., Pearce W.P., Clough L.E., Monk C.R., Leung E., Rowan W.C., Sancho S., Walker L.S., Vanhaesebroeck B., and Okkenhaug K. The phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells. J. Immunol. 177 (2006) 6598-6602
16. Ji H., Rintelen F., Waltzinger C., Bertschy Meier D., Bilancio A., Pearce W., Hirsch E., Wymann M.P., Ruckle T., Camps M., Vanhaesebroeck B., Okkenhaug K., and Rommel C. Inactivation of PI3Kgamma and PI3Kdelta distorts T cell development and causes multiple organ inflammation. Blood 110 (2007) 2940-2947
17. Deane J.A., Kharas M.G., Oak J.S., Stiles L.N., Luo J., Moore T.I., Ji H., Rommel C., Cantley L.C., Lane T.E., and Fruman D.A. T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling. Blood 109 (2007) 2894-2902
18. Oak J.S., Deane J.A., Kharas M.G., Luo J., Lane T.E., Cantley L.C., and Fruman D.A. Sjogren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 16882-16887
19. Rohrschneider L.R., Fuller J.F., Wolf I., Liu Y., and Lucas D.M. Structure, function, and biology of SHIP proteins. Genes Dev. 14 (2000) 505-520
20. Damen J.E., Liu L., Ware M.D., Ermolaeva M., Majerus P.W., and Krystal G. Multiple forms of the SH2-containing inositol phosphatase, SHIP, are generated by C-terminal truncation. Blood 92 (1998) 1199-1205
21. Leung W.H., Tarasenko T., and Bolland S. Differential roles for the inositol phosphatase SHIP in the regulation of macrophages and lymphocytes. Immunol. Res. 43 (2009) 243-251
22. Ooms L.M., Horan K.A., Rahman P., Seaton G., Gurung R., Kethesparan D.S., and Mitchell C.A. The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease. Biochem. J. 419 (2009) 29-49
23. Tu Z., Ninos J.M., Ma Z., Wang J.W., Lemos M.P., Desponts C., Ghansah T., Howson J.M., and Kerr W.G. Embryonic and hematopoietic stem cells express a novel SH2-containing inositol 5′-phosphatase isoform that partners with the Grb2 adapter protein. Blood 98 (2001) 2028-2038
24. Kavanaugh W.M., Pot D.A., Chin S.M., Deuter-Reinhard M., Jefferson A.B., Norris F.A., Masiarz F.R., Cousens L.S., Majerus P.W., and Williams L.T. Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2. Curr. Biol. 6 (1996) 438-445
25. Ono M., Bolland S., Tempst P., and Ravetch J.V. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcγRIIB. Nature 383 (1996) 263-266
26. Liu Q., Oliveira-Dos-Santos A.J., Mariathasan S., Bouchard D., Jones J., Sarao R., Kozieradzki I., Ohashi P.S., Penninger J.M., and Dumont D.J. The inositol polyphosphate 5-phosphatase SHIP is a crucial negative regulator of B cell antigen receptor signaling. J. Exp. Med. 188 (1998) 1333-1342
27. Edmunds C., Parry R.V., Burgess S.J., Reaves B., and Ward S.G. CD28 stimulates tyrosine phosphorylation, cellular redistribution and catalytic activity of the inositol lipid 5-phosphatase SHIP. Eur. J. Immunol. 29 (1999) 3507-3515
28. Freeburn R.W., Wright K.L., Burgess S.J., Astoul E., Cantrell D.A., and Ward S.G. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors. J. Immunol. 169 (2002) 5441-5450
29. Sly L.M., Rauh M.J., Kalesnikoff J., Song C.H., and Krystal G. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity 21 (2004) 227-239
30. Leung W.-H., and Bolland S. The inositol 5′-phosphatase SHIP-2 negatively regulates IgE-induced mast cell degranulation and cytokine production. J. Immunol. 179 (2007) 95-102
31. Ai J., Maturu A., Johnson W., Wang Y., Marsh C.B., and Tridandapani S. The inositol phosphatase SHIP-2 down-regulates FcγR-mediated phagocytosis in murine macrophages independently of SHIP-1. Blood 107 (2006) 813-820
32. Tridandapani S., Kelley T., Pradhan M., Cooney D., Justement L.B., and Coggeshall K.M. Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell Fc gamma immunoreceptor tyrosine-based inhibition motif peptide motif. Mol. Cell. Biol. 17 (1997) 4305-4311
33. Bolland S., Pearse R.N., Kurosaki T., and Ravetch J.V. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 8 (1998) 509-516
34. Osborne M.A., Zenner G., Lubinus M., Zhang X., Songyang Z., Cantley L.C., Majerus P., Burn P., and Kochan J.P. The inositol 5′-phosphatase SHIP binds to immunoreceptor signaling motifs and responds to high affinity IgE receptor aggregation. J. Biol. Chem. 271 (1996) 29271-29278
35. Sly L.M., Ho V., Antignano F., Ruschmann J., Hamilton M., Lam V., Rauh M.J., and Krystal G. The role of SHIP in macrophages. Front. Biosci. 12 (2007) 2836-2848
36. Pradhan M., and Coggeshall K.M. Activation-induced bi-dentate interaction of SHIP and Shc in B lymphocytes. J. Cellular Biochem. 67 (1997) 32-42
37. Lemmon M.A., and Ferguson K.M. Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem. J. 350 (2000) 1-18
38. Dowler S., Currie R.A., Campbell D.G., Deak M., Kular G., Downes C.P., and Alessi D.R. Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities. Biochem. J. 351 (2000) 19-31
39. Marshall A.J., Krahn A.K., Ma K., Duronio V., and Hou S. TAPP1 and TAPP2 are targets of phosphatidylinositol 3-kinase signaling in B cells: sustained plasma membrane recruitment triggered by the B-cell antigen receptor. Mol. Cell. Biol. 22 (2002) 5479-5491
40. Torti M., Bertoni A., Sinigaglia F., Balduini C., Payrastre B., Plantavid M., Chap H., and Mauco G. The platelet cytoskeleton regulates the aggregation-dependent synthesis of phosphatidylinositol 3,4-bisphosphate induced by thrombin. FEBS Letts. 466 (2000) 355-358
41. Ward S.G., Ley S.C., MacPhee C., and Cantrell D.A. Regulation of D-3 phosphoinositides during T cell activation via the T cell antigen receptor/CD3 complex and CD2 antigens. Eur. J. Immunol. 22 (1992) 45-49
42. Tomlinson M.G., Heath V.L., Turck C.W., Watson S.P., and Weiss A. SHIP family inositol phosphatases interact with and negatively regulate the Tec tyrosine kinase. J. Biol. Chem. 279 (2004) 55089-55096
43. Dong S., Corre B., Foulon E., Dufour E., Veillette A., Acuto O., and Michel F. T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2. J. Exp. Med. 203 (2006) 2509-2518
44. Gloire G., Charlier E., Rahmouni S., Volanti C., Chariot A., Erneux C., and Piette J. Restoration of SHIP-1 activity in human leukemic cells modifies NF-kappaB activation pathway and cellular survival upon oxidative stress. Oncogene 25 (2006) 5485-5494
45. Chaigne-Delalande B., Anies G., Kramer I., and Genot E. Nonadherent cells switch to a Rac-mediated, SHIP regulated, Akt activation mode for survival. Oncogene 27 (2008) 1876-1885
46. Genot E.M., Arrieumerlou C., Ku G., Burgering B.M., Weiss A., and Kramer I.M. The T-cell receptor regulates Akt (protein kinase B) via a pathway involving Rac1 and phosphatidylinositide 3-kinase. Mol. Cell. Biol. 20 (2000) 5469-5478
47. Helgason C.D., Damen J.E., Rosten P., Grewal R., Sorensen P., Chappel S.M., Borowski A., Jirik F., Krystal G., and Humphries R.K. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 12 (1998) 1610-1620
48. Nakamura K., Malykhin A., and Coggeshall K.M. The Src homology 2 domain-containing inositol 5-phosphatase negatively regulates Fcgamma receptor-mediated phagocytosis through immunoreceptor tyrosine-based activation motif-bearing phagocytic receptors. Blood 100 (2002) 3374-3382
49. Huber M., Helgason C.D., Damen J.E., Liu L., Humphries R.K., and Krystal G. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 11330-11335
50. Brauweiler A., Tamir I., Marschner S., Helgason C.D., and Cambier J.C. Partially distinct molecular mechanisms mediate inhibitory FcγRIIB signaling in resting and activated B cells. J. Immunol. 167 (2001) 204-211
51. Neill L., Tien A.H., Rey-Ladino J., and Helgason C.D. SHIP-deficient mice provide insights into the regulation of dendritic cell development and function. Exp. Hematol. 35 (2007) 627-639
52. Wahle J.A., Paraiso K.H., Kendig R.D., Lawrence H.R., Chen L., Wu J., and Kerr W.G. Inappropriate recruitment and activity by the Src homology region 2 domain-containing phosphatase 1 (SHP1) is responsible for receptor dominance in the SHIP-deficient NK cell. J Immunol. 179 (2007) 8009-8015
53. Bruyns C., Pesesse X., Moreau C., Blero D., and Erneux C. The two SH2-domain-containing inositol 5-phosphatases SHIP1 and SHIP2 are co-expressed in human T lymphocytes. Biol. Chem. 380 (1999) 969-974
54. +T cell development. J. Immunol. 176 (2006) 3958-3965
55. Locke N.R., Patterson S.J., Hamilton M.J., Sly L.M., Krystal G., and Levings M.K. SHIP regulates the reciprocal development of T regulatory and Th17 cells. J. Immunol. 1833 (2009) 975-983
56. Tarasenko T., Kole H.K., Chi A.W., Mentink-Kane M.M., Wynn T.A., and Bolland S. T cell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1/Th2 and cytotoxic responses. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 11382-11387
57. Sullivan B.M., Juedes A., Szabo S.J., von Herrath M., and Glimcher L.H. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 15818-15823
58. Ward S.G. Do phosphoinositide 3-kinases direct lymphocyte navigation?. Trends Immunol. 25 (2004) 67-74
59. Smith L.D., Hickman E.S., Parry R.V., Westwick J., and Ward S.G. PI3Kgamma is the dominant isoform involved in migratory responses of human T lymphocytes: effects of ex vivo maintenance and limitations of non-viral delivery of siRNA. Cell Signal 19 (2007) 2528-2539
60. Ward S.G. T lymphocytes on the move: chemokines, PI 3-kinase and beyond. Trends Immunol. 27 (2006) 80-87
61. 3 phosphatase SHIP1. Nat. Cell Biol. 9 (2007) 36-44
62. Wain C.M., Westwick J., and Ward S.G. Heterologous regulation of chemokine receptor signaling by the lipid phosphatase SHIP in lymphocytes. Cell Signal 17 (2005) 1194-1202
63. Sheedy F.J., and O'Neill L.A. Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann. Rheum. Dis. 67 Suppl. 3 (2008) iii50-55
64. Rodriguez A., Vigorito E., Clare S., Warren M.V., Couttet P., Soond D.R., van Dongen S., Grocock R.J., Das P.P., Miska E.A., Vetrie D., Okkenhaug K., Enright A.J., Dougan G., Turner M., and Bradley A. Requirement of bic/microRNA-155 for normal immune function. Science 316 (2007) 608-611
65. O'Connell R.M., Chaudhuri A.A., Rao D.S., and Baltimore D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 7113-7118
66. Costinean S., Sandhu S.K., Pedersen I.M., Tili E., Trotta R., Perrotti D., Ciarlariello D., Neviani P., Harb J., Kauffman L.R., Shidham A., and Croce C.M. SHIP and CCAAT enhancer-binding protein beta a are targeted by miR-155 in B cells of Emicro-miR-155 transgenic mice. Blood 114 (2009) 1374-1382
67. Marson A., Kretschmer K., Frampton G.M., Jacobsen E.S., Polansky J.K., MacIsaac K.D., Levine S.S., Fraenkel E., von Boehmer H., and Young R.A. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445 (2007) 931-935
68. Zheng Y., Josefowicz S.Z., Kas A., Chu T.T., Gavin M.A., and Rudensky A.Y. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445 (2007) 936-940
69. Shenker B.J., Dlakic M., Walker L.P., Besack D., Jaffe E., LaBelle E., and Boesze-Battaglia K. A novel mode of action for a microbial-derived immunotoxin: the cytolethal distending toxin subunit B exhibits phosphatidylinositol 3,4,5-triphosphate phosphatase activity. J. Immunol. 178 (2007) 5099-5108
70. Horn S., Endl E., Fehse B., Weck M.M., Mayr G.W., and Jucker M. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle. Leukemia 18 (2004) 1839-1849
71. Avota E., Harms H., and Schneider-Schaulies S. Measles virus induces expression of SIP110, a constitutively membrane clustered lipid phosphatase, which inhibits T cell proliferation. Cell Microbiol. 8 (2006) 1826-1839
72. Avota E., Muller N., Klett M., and Schneider-Schaulies S. Measles virus interacts with and alters signal transduction in T-cell lipid rafts. J. Virol. 78 (2004) 9552-9559
73. Crabbe T., Welham M.J., and Ward S.G. The PI3K inhibitor arsenal: choose your weapon!. Trends Biochem. Sci. 32 (2007) 450-456
74. Ong C.J., Ming-Lum A., Nodwell M., Ghanipour A., Yang L., Williams D.E., Kim J., Demirjian L., Qasimi P., Ruschmann J., Cao L.P., Ma K., Chung S.W., Duronio V., Andersen R.J., Krystal G., and Mui A.L. Small molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells. Blood 110 (2007) 1942-1949
75. +/-mice. Science 285 (1999) 2122-2125
76. Suzuki A., Yamaguchi M.T., Ohteki T., Sasaki T., Kaisho T., Kimura Y., Yoshida R., Wakeham A., Higuchi T., Fukumoto M., Tsubata T., Ohashi P.S., Koyasu S., Penninger J.M., Nakano T., and Mak T.W. T cell-specific loss of PTEN leads to defects in central and peripheral tolerance. Immunity 14 (2001) 523-534
77. Rosivatz E. Inhibiting PTEN. Biochem. Soc. Trans. 35 (2007) 257-259
78. Brognard J., Sierecki E., Gao T., and Newton A.C. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol. Cell 25 (2007) 917-931
79. Gao T., Furnari F., and Newton A.C. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell 18 (2005) 13-24
80. Mendoza M.C., and Blenis J. PHLPPing it off: phosphatases get in the Akt. Mol. Cell 25 (2007) 798-800
81. Wolf I., Lucas D.M., Algate P.A., and Rohrschneider L.R. Cloning of the genomic locus of mouse SH2 containing inositol 5-phosphatase (SHIP) and a novel 110-kDa splice isoform. SHIPdelta, Genomics 69 (2000) 104-112
82. Lucas D.M., and Rohrschneider L.R. A novel spliced form of SH2-containing inositol phosphatase is expressed during myeloid development. Blood 93 (1999) 1922-1933
83. Kuroda E., Ho V., Ruschmann J., Antignano F., Hamilton M., Rauh M.J., Antov A., Flavell R.A., Sly L.M., and Krystal G. SHIP represses the generation of IL-3-induced M2 macrophages by inhibiting IL-4 production from basophils. J. Immunol. 183 (2009) 3652-3660